Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Infectious peritonitis" patented technology

Feline infectious peritonitis (FIP) is the name given to an uncommon, but usually fatal, aberrant immune response to infection with feline coronavirus (FCoV).

Feline infectious peritonitis vaccine

The invention comprises the nucleotide sequences comprising the FIPV S gene, or a fragment of this gene, which are modified in at least one of the antigenic regions A1 and A2 which are involved in enhancement, as well as the use of these sequences for the expression of modified proteins, and for the construction of recombinant viruses or expression plasmids, and the use of the recombinant viruses as vaccines against feline infectious peritonitis, the use of the expression plasmids as immunizing composition by direct injection of the said plasmids into cats, and the use of the modified proteins as vaccine.
Owner:MERIAL SAS

Vaccine for feline infectious peritonitis

FIP vaccines were provided that use an N protein with a specific structure, or a fragment thereof, as an antigen. Preferred antigens of this invention are N proteins derived from a specific type I virus strain (KU-2). Vaccines comprising such an N protein confer preventive effects against a wide range of FIPVs. In addition, the N proteins are very safe because they do not comprise epitopes that enhance infection. Furthermore, preventive effects can be accomplished against type I viruses, which actually cause 70% or more of FIP.
Owner:KITASATO DAIICHI SANKYO VACCINE

Reagent kid for quantitatively testing mRNA (messenger ribonucleic acid) level of FIP1L1-PDGFRA (feline infectious peritonitis 1 like 1-platelet-derived growth factor receptor alpha) fusion genes

InactiveCN102827935AGuaranteed specific amplificationAccurately reflect tumor burdenMicrobiological testing/measurementFluorescence/phosphorescenceFip1l1 pdgfraPlatelet-Derived Growth Factor Receptor Alpha
The invention discloses a reagent kit for quantitatively testing mRNA (messenger ribonucleic acid) level of FIP1L1-PDGFRA (feline infectious peritonitis 1 like 1-platelet-derived growth factor receptor alpha) fusion genes. The test reagent contains upstream primers I, downstream primers I and TaqMan probes I which are used for real-time quantitative PCR (polymerase chain reaction) testing for mRNA of the FIP1L1-PDGFRA fusion genes. The upstream primers I include at least one of single-chain DNA (deoxyribose nucleic acid) shown as sequences 1, 2, 3, 4 and 5 in a sequence table, the downstream primers I include at least one of two single-chain DNA as shown in sequence 9 and 10 in the sequence table, and the TaqMan probes I include at least one of two single-chain DNA as shown in sequences 9 and 10 in the sequence table. The reagent kit has the advantages of speediness, simplicity, convenience and the like in testing, common types of FIP1L1-PDGFRA fusion genes can be covered in one experiment, and the mRNA level of the FIP1L1-PDGFRA fusion genes can be tested. The reagent kit can be used for FIP1L1-PDGFRA fusion gene screening and therapeutic evaluation for eosinophilia patients, and further can be used for monitoring minimal residual diseases.
Owner:PEOPLES HOSPITAL PEKING UNIV

Traditional Chinese medicine composition for treating feline infectious peritonitis

The invention provides a traditional Chinese medicine composition for treating feline infectious peritonitis, which comprises the following traditional Chinese medicine components: radix puerariae, Snphora angustifolia, radix scutellariae, Herba Lycopi, dandelion, radix bupleuri, milk veteh, and radix codonopsitis. According to the method of Chinese veterinary medicine dialectical therapy, radix puerariae has the effects of releasing the exterior and relieving the muscles and skin, removing fever and promoting eruption, promoting the production of body fluid to quench thirst, lifting yang and relieving diarrhea; Snphora angustifolia has the effects of clearing heat and drying damp, dispersing pathogenic wind, killing parasites to relieve itching and promoting urination; radix scutellariae has the effects of clearing heat and drying damp, purging intense heat and detonicating; Herba Lycopi has the effects of promoting blood circulation by removing blood stasis and inducing diuresis for removing edema; dandelion has the effects of clearing away heat and toxic material and removing swelling and stasis; radix bupleuri has the effects of expelling surficial evils and heat-evil, soothing liver-qi stagnation and lifting yang; milk veteh has the effects of invigorating qi for securing the exterior, draining water and reducing swelling, draining pus and expelling toxin and promoting tissue regeneration; and radix codonopsitis has the effects of tonifying middle-Jiao and Qi, strengthening the spleen and replenishing lung. According to combined action of radix puerariae, Snphora angustifolia, radix scutellariae, Herba Lycopi, dandelion, radix bupleuri, milk veteh, and radix codonopsiti, feline infectious peritonitis can be efficiently treated.
Owner:TIANJIN JIHE TECH

Primers for cat coronavirus gene amplification and genotyping method

The invention relates to a cat coronavirus gene amplification primer and a genotyping method. The primer is a cat coronavirus S gene primer, and a high-resolution melting curve (HRM) identification method of an SNP site (g.23531A>Y) on a cat coronavirus fibrin gene S can be established by applying the primer. A detection method established by applying the primer can be used for rapidly detecting and identifying the genotype of the 23531st site of the cat coronavirus genome from a pet clinical sample; and thus, and then the systemic infectivity phenotype of the corresponding strain can be deduced, so that the primer can be used as a basis for screening pathogenicity of the cat coronavirus, and can also be used as an important reference for clinical diagnosis of infectious peritonitis of cats.
Owner:LUDONG UNIVERSITY +1

Egg yolk antibody composition for cat infectious peritonitis as well as preparation method and application of egg yolk antibody composition

ActiveCN114835804AEffective treatment of feline infectious peritonitisGood effectEgg immunoglobulinsSsRNA viruses positive-senseEnteric coronavirus infectionCross infections
The invention belongs to the technical field of gene recombination and antibody preparation, and particularly discloses a cat infectious peritonitis egg yolk antibody composition as well as a preparation method and application thereof. The composition is obtained by mixing a feline intestinal coronavirus S protein egg yolk antibody, a type I feline infectious peritonitis virus S protein egg yolk antibody and a type II feline infectious peritonitis virus S protein egg yolk antibody according to the mass ratio of (1-2): (1-2): (1-2) under the same titer, and compared with a single antibody, the two antibodies are mixed to form the composition. And the three antibodies are mixed according to other proportions, so that the effect of treating feline infectious peritonitis is good. The traditional Chinese medicine composition not only can neutralize cat intestinal coronavirus infection without clinical symptoms so as to prevent cat infectious peritonitis virus infection, but also can neutralize infection of cat infectious peritonitis type I and type II with clinical symptoms so as to achieve the effect of treating cat infectious peritonitis. And particularly, the compound has a relatively good treatment effect on cross infection of type I and type II cat infectious peritonitis viruses.
Owner:安徽中起生物科技有限公司

Fluorescent quantitative RT-PCR detection kit for feline infectious peritonitis virus

The invention relates to a fluorescent quantitative RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection kit for a feline infectious peritonitis virus. The kit comprises a specific primer for fluorescent quantitative RT-PCR detection of the feline infectious peritonitis virus and a TaqMan probe, wherein the sequence of the forward primer is SEQ ID NO: 2, and the sequence of the reverse primer is SEQ ID NO: 3; the sequence of the TaqMan probe is as shown in SEQ ID NO: 4. The kit has good sensitivity, specificity and stability, is suitable for rapid diagnosis in the early stage of feline infectious peritonitis virus infection, and has important significance for reducing the transmission of feline infectious peritonitis and improving the detection efficiency of feline infectious peritonitis.
Owner:昆明海关技术中心

Conditioning paste for treating cat abdominal infection and preparation method of conditioning paste

The invention discloses conditioning paste for treating cat abdominal infection and a preparation method of the conditioning paste. The conditioning paste is prepared from the following components: Chinese herbaceous peony, raw liquorice, codonopsis pilosula, bighead atractylodes rhizome, pericarpium citri reticulatae, cortex moutan, salvia miltiorrhiza, red paeony root, radix bupleuri, patrinia, selfheal, dandelion, Chinese waxgourd seed, honeysuckle, radix stemonae and ginger. The feline infectious peritonitis is a chronic, progressive and lethal infectious disease caused by feline infectious peritonitis virus, has the main characteristics of peritonitis, accumulation of a large amount of ascites and high fatality rate, and has the external symptoms of stomachache, nausea and vomiting, fever, unclear recognition and the like. According to the invention, the Chinese herbaceous peony and the raw licorice are used as monarch drugs for nourishing liver, relieving spasm and pain, clearing heat and detoxifying. Codonopsis pilosula, atractylodes macrocephala koidz and pericarpium citri reticulatae are adopted to promote transportation and transformation of spleen and stomach of pets and enhance autoimmunity, radix stemonae and ginger are adopted to kill insects and bacteria, and the death rate of infected cats on the abdomen is reduced by adopting prevention and conditioning principles.
Owner:深圳市旺金生物科技有限公司

Use of HPK1 kinase inhibitors for prevention and/or treatment of pathogen infections in animals

The invention discloses an application of an HPK1 kinase inhibitor in preventing and / or treating pathogen infection of animals. The HPK1 kinase inhibitor is a small-molecule HPK1 kinase inhibitor, in particular a compound shown in a general formula I or pharmaceutically acceptable salt, stereoisomer, ester, prodrug, solvate or deuterated compound thereof. The HPK1 kinase inhibitor can be used for effectively treating diseases (such as feline infectious peritonitis) caused by animal pathogen (especially virus such as coronavirus) infection and improving the survival condition of animals, and has better commercial value and application prospect in the field of veterinary antiviral (especially virus such as coronavirus) medicines.
Owner:ZHUHAI YUFAN BIOTECHNOLOGIES CO LTD

Reagent kid for quantitatively testing mRNA (messenger ribonucleic acid) level of FIP1L1-PDGFRA (feline infectious peritonitis 1 like 1-platelet-derived growth factor receptor alpha) fusion genes

InactiveCN102827935BGuaranteed specific amplificationAccurately reflect tumor burdenMicrobiological testing/measurementDeoxyriboseInfectious peritonitis
The invention discloses a reagent kit for quantitatively testing mRNA (messenger ribonucleic acid) level of FIP1L1-PDGFRA (feline infectious peritonitis 1 like 1-platelet-derived growth factor receptor alpha) fusion genes. The test reagent contains upstream primers I, downstream primers I and TaqMan probes I which are used for real-time quantitative PCR (polymerase chain reaction) testing for mRNA of the FIP1L1-PDGFRA fusion genes. The upstream primers I include at least one of single-chain DNA (deoxyribose nucleic acid) shown as sequences 1, 2, 3, 4 and 5 in a sequence table, the downstream primers I include at least one of two single-chain DNA as shown in sequence 9 and 10 in the sequence table, and the TaqMan probes I include at least one of two single-chain DNA as shown in sequences 9 and 10 in the sequence table. The reagent kit has the advantages of speediness, simplicity, convenience and the like in testing, common types of FIP1L1-PDGFRA fusion genes can be covered in one experiment, and the mRNA level of the FIP1L1-PDGFRA fusion genes can be tested. The reagent kit can be used for FIP1L1-PDGFRA fusion gene screening and therapeutic evaluation for eosinophilia patients, and further can be used for monitoring minimal residual diseases.
Owner:PEOPLES HOSPITAL PEKING UNIV

Nucleoside compound and application thereof in treating feline infectious peritonitis

The invention relates to a nucleoside compound and application of the nucleoside compound in treatment of feline infectious peritonitis. The compound belongs to a GS-441524 analogue. The compound has a very small toxic effect on normal cells of cats, and has an obvious inhibition effect on feline coronavirus. The compound can be used for preparing a feline coronavirus inhibitor, is used for treating feline infectious peritonitis, has the advantages of good curative effect, high safety and the like, and is very good in water solubility and easier to absorb.
Owner:SUZHOU VIGONVITA LIFE SCIENCES CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products